Revenues of bioAffinity Technologies, Inc. from 30 Sep 2022 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
bioAffinity Technologies, Inc. annual and quarterly Revenues in USD history and change rate from 30 Sep 2022 to 31 Dec 2023.
  • bioAffinity Technologies, Inc. Revenues for the quarter ending 30 Sep 2023 was $300,236.
  • bioAffinity Technologies, Inc. annual Revenues for 2023 was $7,900,000, a 14% increase from 2022.
Source SEC data
View on sec.gov
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)
Revenues, Quarterly (USD)

bioAffinity Technologies, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $7,900,000 +$1,000,000 +14% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $6,900,000 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY

bioAffinity Technologies, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $300,236 +$299,086 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q1 2023 $1,806,196 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 $1,150* 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.